Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical impact of the COVID-19 pandemic on daily urological practice: first 3-month multicenter results from İstanbul.
Çakıcı MÇ, Temiz MZ, İplikçi A, Özgör F, Aksoy AK, Özer M, Erdem S, Ulus İ, Küçük EV, Ötünçtemur A, Değirmenci E, Aydın R, Atış G, Müslümanoğlu AY, Sarılar Ö, Özcan F, Yıldırım A. Çakıcı MÇ, et al. Among authors: degirmenci e. Turk J Med Sci. 2021 Jun 28;51(3):962-971. doi: 10.3906/sag-2009-184. Turk J Med Sci. 2021. PMID: 33433971 Free PMC article.
Impact of delay in cystoscopic surveillance on recurrence and progression rates in patients with non-muscle-invasive bladder cancer during the COVID-19 pandemic.
Culpan M, Keser F, Acar HC, Otunctemur A, Kucuk EV, Erdem S, Ozer M, Sen UT, Degirmenci E, Ergul R, Atis RG, Yildirim A. Culpan M, et al. Among authors: degirmenci e. Int J Clin Pract. 2021 Sep;75(9):e14490. doi: 10.1111/ijcp.14490. Epub 2021 Jun 22. Int J Clin Pract. 2021. PMID: 34117682 Free PMC article.
How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.
Erdem S, Simsek DH, Degirmenci E, Aydin R, Bagbudar S, Ozluk Y, Sanli Y, Sanli O, Ozcan F. Erdem S, et al. Among authors: degirmenci e. Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13. Urol Oncol. 2022. PMID: 34400066
External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis.
Erdem S, Capitanio U, Campi R, Mir MC, Roussel E, Pavan N, Kara O, Klatte T, Kriegmair MC, Degirmenci E, Aydin R, Minervini A, Serni S, Berni A, Rebez G, Ozcan F; European Association of Urology (EAU)-Young Academic Urologists (YAU) Renal Cancer Working Group. Erdem S, et al. Among authors: degirmenci e. Urol Oncol. 2022 May;40(5):198.e9-198.e17. doi: 10.1016/j.urolonc.2022.01.006. Epub 2022 Feb 13. Urol Oncol. 2022. PMID: 35172939
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S, Bertolo R, Campi R, Capitanio U, Amparore D, Anceschi U, Mir MC, Roussel E, Pavan N, Carbonara U, Kara O, Klatte T, Marchioni M, Pecoraro A, Muselaers S, Marandino L, Diana P, Borregales L, Palumbo C, Warren H, Wu Z, Calio A, Ciccarese C, Degirmenci E, Aydin R, Rebez G, Schips L, Simone G, Minervini A, Serni S, Ozcan F. Erdem S, et al. Among authors: degirmenci e. Urol Oncol. 2024 May;42(5):163.e1-163.e13. doi: 10.1016/j.urolonc.2024.01.028. Epub 2024 Mar 5. Urol Oncol. 2024. PMID: 38443238
Voiding Cystourethrogram Before Pyeloplasty: To Do or Not To Do?
Selvi I, Dönmez Mİ, Değirmenci E, Zoroğlu H, Ziylan O, Oktar T. Selvi I, et al. Among authors: degirmenci e. Urology. 2024 Feb;184:182-188. doi: 10.1016/j.urology.2023.10.003. Epub 2023 Oct 20. Urology. 2024. PMID: 37866651
63 results